凤凰时尚网移动版

The development of Chinese Magnoliavine enjoys broad development prospects. Viewing from the current market situation analysis, the development of Chinese Magnoliavine medical products and health foods, as well as the changes in people's consumption habits and diet structure, the demand for Chinese Magnoliavine at home and abroad increased, and the supply of Chinese Magnoliavine was in short supply. In response to this situation, in recent years, domestic economic forest experts have studied the cultivation of wild resources of Chinese Magnoliavine, selection of excellent varieties, and establishment of artificial high-yield cultivation models, and selected a number of valuable new varieties and new strains, such as "red pearls", "pink pearls", "red agate", etc., laying a solid foundation for raw material supply for the industrialization of Chinese Magnoliavine food. Therefore, the development of Chinese Magnoliavine food has a large domestic and international market, and broad development prospects.

Chinese Magnoliavine is a traditional Chinese medicine variety with regional characteristics. It is also a backbone variety of local medicines in the North Pharmaceutical Base and Jilin Province. The use of medicinal resources of Chinese Magnoliavine has sharply increased the demand for drugs or health care products for treating insomnia or improving sleep. Although the western medicine preparation has a quick effect, it has a relatively large side effect and is prone to dependence; it needs to gradually increase the dose to maintain sleep for long-term use. Therefore, the introduction of this product into the market will produce better economic benefits with broad prospects.

1.1.3 Technical Analysis

This project intends to adopt the independent research and development patent technology of Jilin University, which is mature and highly feasible.

1.1.4 Advantages of Project Construction

(1) Policy advantages

The State vigorously supports the development of Chinese herbal medicines and promulgated the Outline of Chinese Medicine Innovation Development Plan (2006-2020), hoping to seek the legal status of Chinese medicine, strive to improve the Chinese medicine disease prevention and treatment, diagnosis and treatment technology system, and promote the inheritance, innovation and sustainable development of traditional Chinese medicines. The Outline proposes that by 2020 the Chinese government will establish an internationally recognized standard system for Chinese medicines. Efforts will be made to promote Chinese medicine into hospitals, pharmacies and medical insurance systems in Western countries. The State Council also promulgated the Several Opinions of the State Council on Supporting and Promoting the Development of Traditional Chinese Medicine, proposing to establish a leadership coordination mechanism, an administrative management system, an input compensation mechanism, and an operational guarantee mechanism to guarantee the scientific development of Chinese medicine.

Jilin Province has been committed to build a service-oriented government, shaping a favorable business environment for investors. The Implementation Opinions of the People's Government of Jilin Province on Supporting and Promoting the Development of Traditional Chinese Medicine was promulgated accordingly. In the “13th Five-Year” development plan of the province, the pharmaceutical industry is listed as one of industries strongly supported and developed. The government where the project is located is very supportive of such projects, and can design supporting policies for the project by means of “one mater, one discussion”.

(2) Industrial advantages

Jilin Province is very suitable for technology research and development and product industrialization of the pharmaceutical industry. There are the largest biomedical laboratories in Asia, nearly one-third of the country's vaccine companies, sufficient chemical, biological and Chinese medicine raw materials. In addition, there are a large number of medical talents and the largest hospitals in the three provinces of Northeast China with the highest scale. It is a favorable place for the industrialization of medical technology, with a very sound upstream and downstream industry advantage.

Shulan Chengbei Medicine and Health Products Industrial Park is mainly engaged in bio-pharmaceuticals, health care products and other industrial projects, striving to create itself to be the “Changbai Mountain Special Resources and Pharmaceutical Industry Demonstration Zone of Jilin Province”. It has formed an industrial chain cluster effect.

(3) Location advantages